Macrophage Apoptosis in Atherogenesis
动脉粥样硬化形成中的巨噬细胞凋亡
基本信息
- 批准号:6905206
- 负责人:
- 金额:$ 37.9万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-04-01 至 2009-03-31
- 项目状态:已结题
- 来源:
- 关键词:BCL2 gene /proteinapolipoprotein Eapoptosisatherosclerotic plaquegenetically modified animalshematopoietic stem cellslaboratory mouseleukocyte activation /transformationlow density lipoprotein receptormacrophagemass spectrometrypathologic processproteolysisstem cell transplantationtransfectionvascular smooth muscle
项目摘要
DESCRIPTION (provided by applicant): Monocyte-derived macrophages are critically involved in the initiation and progression of the atherosclerotic plaque in man as well as in experimental models. Plaque rupture is thought to be the trigger event for acute coronary syndromes in man, and several mouse, models of plaque rupture have been described. Macrophages have been implicated in plaque rupture by releasing de-stabilizing proteases. Macrophage apoptosis is prominent in advanced atherosclerotic lesions, but it is controversial whether macrophage apoptosis is beneficial or detrimental. In this proposal we will examine the mechanisms and consequences of macrophage apopotosis in experimental atherogenesis. We propose that macrophage accumulation and activation in the intima contributes to smooth muscle cell death and thereby promotes plaque rupture. Therefore, we will test the primary hypothesis that macrophage apoptosis reduces intimal lesion progression and ultimately contributes to plaque stabilization. As secondary hypotheses, we also propose that Fasmediated signaling plays an important role in macrophage apoptosis and activation in atherogenesis. In Aim 1, we will identify components of the Fas signaling complex regulating activation versus apoptosis in macrophages in vitro, using isotope-coded affinity tag and tandem affinity purification with mass spectrometry. In Aim 2, we will determine the role of apoptosis proteins in macrophage activation and apoptosis in vitro. We will investigate the effect of the anti-apoptotic proteins, c-FLIP, Bcl-2, dominant-negative FADD, and p35 caspase inhibitor, on macrophage activation or apoptosis in response to Fas ligation or atherogenic stimuli. In Aim 3, we will determine the effect of blockade of macrophage apoptosis on lesion progression and plaque rupture in LDLR-/-and ApoE-/-mice. We will transduce hematopoietic stem cells (HSCs) with a novel retrbviral vector incorporating the macrophage-restricted human CD68 promoter and encoding 1 of the antiapoptotic proteins. We will then determine the effect of transplantation of HSCs transduced with a virus encoding 1 of these anti-apoptotic proteins on early and advanced lesions and plaque rupture in LDLR-/- mice. Positive results with transplantion of transduced HSC in the LDLR-/-model will be extended to lesion initiation/progression and plaque rupture in the ApoE-/-model by generating transgenic ApoE-/- mice overexpressing Bcl-2 selectively in macrophages.
描述(由申请人提供):单核细胞衍生的巨噬细胞在人类以及实验模型中关键参与动脉粥样硬化斑块的引发和进展。斑块破裂被认为是人类急性冠状动脉综合征的触发事件,并且已经描述了几种小鼠斑块破裂模型。巨噬细胞通过释放不稳定的蛋白酶参与斑块破裂。巨噬细胞凋亡在晚期动脉粥样硬化病变中很突出,但巨噬细胞凋亡是否有益还是有害仍存在争议。在本提案中,我们将研究实验性动脉粥样硬化形成中巨噬细胞凋亡的机制和后果。我们认为内膜中巨噬细胞的积累和激活有助于平滑肌细胞死亡,从而促进斑块破裂。因此,我们将检验巨噬细胞凋亡减少内膜病变进展并最终有助于斑块稳定的主要假设。作为次要假设,我们还提出 Fas 介导的信号在动脉粥样硬化形成中的巨噬细胞凋亡和激活中发挥重要作用。在目标 1 中,我们将使用同位素编码的亲和标签和质谱串联亲和纯化,在体外鉴定调节巨噬细胞激活与凋亡的 Fas 信号复合物的成分。在目标 2 中,我们将确定凋亡蛋白在体外巨噬细胞激活和凋亡中的作用。我们将研究抗凋亡蛋白、c-FLIP、Bcl-2、显性失活 FADD 和 p35 caspase 抑制剂对 Fas 连接或致动脉粥样硬化刺激引起的巨噬细胞活化或凋亡的影响。在目标 3 中,我们将确定阻断巨噬细胞凋亡对 LDLR-/- 和 ApoE-/- 小鼠病变进展和斑块破裂的影响。我们将用一种新型逆转录病毒载体转导造血干细胞 (HSC),该载体包含巨噬细胞限制性人 CD68 启动子并编码 1 种抗凋亡蛋白。然后,我们将确定用编码其中一种抗凋亡蛋白的病毒转导的 HSC 移植对 LDLR-/- 小鼠的早期和晚期病变以及斑块破裂的影响。通过生成在巨噬细胞中选择性过表达 Bcl-2 的转基因 ApoE-/- 小鼠,在 LDLR-/- 模型中移植转导的 HSC 的阳性结果将扩展到 ApoE-/- 模型中的病变起始/进展和斑块破裂。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JOHN Marshall HARLAN其他文献
JOHN Marshall HARLAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JOHN Marshall HARLAN', 18)}}的其他基金
Endothelial Toll-Like Receptor-4 Signaling in Sepsis
脓毒症中的内皮 Toll 样受体 4 信号转导
- 批准号:
7031621 - 财政年份:2005
- 资助金额:
$ 37.9万 - 项目类别:
Endothelial Toll-Like Receptor-4 Signaling in Sepsis
脓毒症中的内皮 Toll 样受体 4 信号转导
- 批准号:
7418682 - 财政年份:2005
- 资助金额:
$ 37.9万 - 项目类别:
Endothelial Toll-Like Receptor-4 Signaling in Sepsis
脓毒症中的内皮 Toll 样受体 4 信号转导
- 批准号:
6923080 - 财政年份:2005
- 资助金额:
$ 37.9万 - 项目类别:
VLA-4 and VCAM-1 in Advanced Atherosclerosis
VLA-4 和 VCAM-1 在晚期动脉粥样硬化中的作用
- 批准号:
7140037 - 财政年份:2005
- 资助金额:
$ 37.9万 - 项目类别:
VLA-4 And VCAM-1 in Advanced Atherosclerosis
VLA-4 和 VCAM-1 在晚期动脉粥样硬化中的作用
- 批准号:
6858453 - 财政年份:2005
- 资助金额:
$ 37.9万 - 项目类别:
Endothelial Toll-Like Receptor-4 Signaling in Sepsis
脓毒症中的内皮 Toll 样受体 4 信号转导
- 批准号:
7226200 - 财政年份:2005
- 资助金额:
$ 37.9万 - 项目类别:
相似海外基金
Role of human apolipoprotein E isoforms in long-term effects of West Nile Virus exposure on Alzheimer's disease-related behavioral alteration, cognitive injury, neuroinflammation, and neuropathology
人类载脂蛋白 E 同工型在西尼罗河病毒暴露对阿尔茨海默病相关行为改变、认知损伤、神经炎症和神经病理学的长期影响中的作用
- 批准号:
10658408 - 财政年份:2023
- 资助金额:
$ 37.9万 - 项目类别:
A Therapeutic Role for Apolipoprotein-E in the Germ Theory of Alzheimer's Dementia
载脂蛋白-E 在阿尔茨海默氏痴呆病菌理论中的治疗作用
- 批准号:
10601779 - 财政年份:2023
- 资助金额:
$ 37.9万 - 项目类别:
Investigating how apolipoprotein E genotypes modify fatty acid metabolism
研究载脂蛋白 E 基因型如何改变脂肪酸代谢
- 批准号:
RGPIN-2018-06116 - 财政年份:2022
- 资助金额:
$ 37.9万 - 项目类别:
Discovery Grants Program - Individual
Targeting apolipoprotein E for Alzheimer's disease therapy.
靶向载脂蛋白 E 治疗阿尔茨海默病。
- 批准号:
22K06460 - 财政年份:2022
- 资助金额:
$ 37.9万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The role of apolipoprotein E in Alzheimer's adaptive immunity
载脂蛋白E在阿尔茨海默病适应性免疫中的作用
- 批准号:
10674878 - 财政年份:2022
- 资助金额:
$ 37.9万 - 项目类别:
Apolipoprotein E and immunometabolism in Alzheimer's disease
载脂蛋白 E 和阿尔茨海默病的免疫代谢
- 批准号:
10388528 - 财政年份:2022
- 资助金额:
$ 37.9万 - 项目类别:
The role of apolipoprotein E in Alzheimer's adaptive immunity
载脂蛋白E在阿尔茨海默病适应性免疫中的作用
- 批准号:
10515592 - 财政年份:2022
- 资助金额:
$ 37.9万 - 项目类别:
Apolipoprotein E and immunometabolism in Alzheimer's disease
载脂蛋白 E 与阿尔茨海默病的免疫代谢
- 批准号:
10644996 - 财政年份:2022
- 资助金额:
$ 37.9万 - 项目类别:
Apolipoprotein E glycosylation and its role in Alzheimer's disease pathogenesis
载脂蛋白E糖基化及其在阿尔茨海默病发病机制中的作用
- 批准号:
10601040 - 财政年份:2021
- 资助金额:
$ 37.9万 - 项目类别:
Impact of cysteine modifications of apolipoprotein E on the remnant lipoprotein metabolism
载脂蛋白E半胱氨酸修饰对残余脂蛋白代谢的影响
- 批准号:
21K07310 - 财政年份:2021
- 资助金额:
$ 37.9万 - 项目类别:
Grant-in-Aid for Scientific Research (C)